News
HIMS
27.71
-4.87%
-1.42
INVESTOR DEADLINE: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline
PR Newswire · 8h ago
HIMS Deadline: Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders to Contact the Firm for Information About Their Rights
Barchart · 14h ago
Hims & Hers Health (HIMS) Stock May Trade At A Discount To Sales
Simply Wall St · 1d ago
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
PR Newswire · 1d ago
Noteworthy Friday Option Activity: UNH, HIMS, VEL
NASDAQ · 2d ago
Hims & Hers Defends Subscription Practices And Privacy Disclosures Against Lawsuit
Benzinga · 2d ago
HIMS 10-DAY DEADLINE ALERT: Hims & Hers Health Facing Securities Class Action Lawsuit, Investors with Losses Encouraged to Contact Hagens Berman
PR Newswire · 2d ago
Hims & Hers Health Shares Slid Even Though Sales Rose
Simply Wall St · 2d ago
Hims & Hers ($HIMS) Seeks Dismissal of FTC Lawsuit Over Subscriptions and Privacy
Barchart · 2d ago
Hims & Hers Asks Judge to Toss FTC Lawsuit Over Subscription Payments and User Data
TipRanks · 3d ago
'Hims Seeks Dismissal of FTC Suit Over User Data, Subscriptions' - Bloomberg News
Benzinga · 3d ago
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
PR Newswire · 3d ago
INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline - HIMS
PR Newswire · 4d ago
HIMS 12-DAY DEADLINE ALERT: Hims & Hers Health Faces Securities Fraud Class Action, Investors with Losses Encouraged to Contact Hagens Berman
PR Newswire · 4d ago
Hims announces launch of new injectable and oral TRT options
TipRanks · 4d ago
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
Barchart · 4d ago
Hims & Hers gains after German launch
Seeking Alpha · 5d ago
Moderately bullish activity in Hims and Hers Health with shares up 4.33%
TipRanks · 5d ago
Hims & Hers Health (HIMS) Gets A Fresh Valuation Test After UK And Australia Push
Simply Wall St · 5d ago
Hims & Hers Health (NYSE: HIMS) Facing Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower
PR Newswire · 5d ago
More
Webull provides a variety of real-time HIMS stock news. You can receive the latest news about Hims & Hers Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About HIMS
Hims & Hers Health, Inc. operates as a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud-enabled pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of conditions, including primarily those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products.